User contributions
Jump to navigation
Jump to search
- 08:54, 21 October 2024 diff hist +6,493 N Typical time to progression with TKIbased treatments right after failure of immunooncology treatments within metastatic elimination most cancers A systematic assessment and also metaanalysis Created page with "95, 95% confidence interval [CI] 1.13-3.34, P=0.0154), as well as the log-transformed CACS (adjusted HR 1.24, 95% CI 1.11-1.39, P=0.0002) and the presence of obstructive steno..." current